Ecopipam Treatment of Tourette's
Protocol ID
PSY301, 10-02-226-03
Protocol Description
This clinical research study is designed to investigate the use of a new drug, ecopipam, in the treatment of Tourette's Disorder.
Eligibility Criteria
Adults 18+ with a diagnosis of Tourette's Disorder
Primary Investigator(s)
- Cathy L. Budman, MD